Altre lingue Tempus AI, Inc

Azioni

Mercato chiuso - Nasdaq Altri mercati azionari 22:00:00 11/07/2024			Variaz. 5gg	Var. 1 gen.
37,5 ^USD	+7,14%		+9,04%	0,00%

09/07	Analisti di Wall Street rialzisti sull'azienda di test genetici Tempus AI	RE
09/07	Il Nasdaq e l'S&P 500 hanno toccato dei record, spinti da Nvidia	RE

Tempus Surpasses 500 Research Publications	10/07
Wall Street analysts bullish on genetic testing firm Tempus AI	09/07
Nasdaq and S&P 500 hit records, fueled by Nvidia	09/07
Sector Update: Health Care Stocks Rise in Afternoon Trading	09/07
Tempus AI Poised for 27% Topline Growth Through 2028, Morgan Stanley Says	09/07
Chip stocks, megacaps steer S&P 500, Nasdaq to record highs	09/07
Wall Street analysts bullish on genetic testing firm Tempus AI	09/07
Wall Street ouvre en hausse avant le discours de Powell	09/07
Futures higher as megacaps, chip stocks rise ahead of Powell comments	09/07
American Medical Association Grants PLA Code to Tempus Algorithmic Test, PurISTSM	08/07
Tempus AI, Inc Announces American Medical Association Grants PLA Code to Tempus Algorithmic Test, PurlSTSM	08/07
Tempus AI Gets Advanced Diagnostic Laboratory Test Status For Sequencing Test From CMS	02/07
CMS Awards Tempus With Advanced Diagnostic Laboratory Test (ADLT) Status for its xT CDx Test	02/07
CMS Awards Tempus AI, Inc. with Advanced Diagnostic Laboratory Test Status for its xT CDx Test	02/07
Biopharma firm Alumis' shares fall nearly 16% in Nasdaq debut	28/06
SoftBank Group to Form Joint Venture with Tempus AI	27/06
SoftBank Group to Form Joint Venture With U.S. Healthcare Firm Tempus AI	27/06
SoftBank Group launches AI healthcare joint venture with Tempus AI	27/06
Tempus AI's Atrial Fibrillation Risk Detection Device Gets FDA Clearance	26/06
Tempus AI Gets 510(k) Clearance for ECG-AF Device	26/06

Non ci sono risultati per questa ricerca